Rosett Max plan to sell securities of Immunome Inc. under Form 144

Rosett Max filed Form 144 to notify SEC of plan to sell 65000 units of Immunome Inc. securities around 2026-04-02, with aggregate market value of $4,723,550.00. The total outstanding units is 113133199.0. The amount planned to be sold represents 0.06% of total outstanding units;